Alexandre Prat

Affiliations: 
Immunology and Microbiology Université de Montréal, Montréal, Canada 
Area:
Immunology, Neuroscience Biology
Google:
"Alexandre Prat"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Michel L, Grasmuck C, Charabati M, et al. (2019) Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers. Science Translational Medicine. 11
Fambiatos A, Jokubaitis V, Horakova D, et al. (2019) Risk of secondary progressive multiple sclerosis: A longitudinal study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519868990
Takenaka MC, Gabriely G, Rothhammer V, et al. (2019) Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nature Neuroscience
Ayrignac X, Bilodeau PA, Prat A, et al. (2019) Assessing the risk of multiple sclerosis disease-modifying therapies. Expert Review of Neurotherapeutics
Brown JWL, Coles A, Horakova D, et al. (2019) Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. Jama. 321: 175-187
Kalincik T, Kubala Havrdova E, Horakova D, et al. (2019) Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry
Dhaeze T, Tremblay L, Lachance C, et al. (2019) CD70 defines a subset of proinflammatory and CNS-pathogenic T1/T17 lymphocytes and is overexpressed in multiple sclerosis. Cellular & Molecular Immunology
Nguyen AL, Havrdova EK, Horakova D, et al. (2019) Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study. Multiple Sclerosis and Related Disorders. 28: 235-243
Lorscheider J, Kuhle J, Izquierdo G, et al. (2018) Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. European Journal of Neurology
Hughes J, Jokubaitis V, Lugaresi A, et al. (2018) Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis. Jama Neurology
See more...